ProfileGDS4459 / ENSG00000125788
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 16% 7% 18% 26% 25% 14% 19% 14% 19% 21% 21% 16% 20% 12% 19% 10% 8% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 13.1516
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 22.87
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 32.8418
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 43.7226
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 53.3825
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 62.9314
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 72.9719
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 82.6514
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 92.919
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 103.1521
GSM623474group B, liver allograft wedge biopsie placebo treatment 13.2221
GSM623475group B, liver allograft wedge biopsie placebo treatment 22.7116
GSM623476group B, liver allograft wedge biopsie placebo treatment 33.0620
GSM623477group B, liver allograft wedge biopsie placebo treatment 43.0812
GSM623478group B, liver allograft wedge biopsie placebo treatment 52.9219
GSM623479group B, liver allograft wedge biopsie placebo treatment 62.9410
GSM623480group B, liver allograft wedge biopsie placebo treatment 72.798